Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7676 - 7700 of 9386 in total

3,4-Dihydro-5-Methyl-Isoquinolinone

Experimental

4-Hydroxy-Aconitate Ion

Experimental

4-PIPERIDIN-4-YLBUTANAL

Experimental

2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate

Experimental

N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide

Experimental

Clinofibrate

Clinofibrate is a fibrate drug sold and marketed in Japan.
Experimental

Gefarnate

Gefarnate has been investigated for the treatment and prevention of Stomach Ulcer, Duodenal Ulcer, and Cardio-cerebrovascular Disease.
Investigational

Simendan

Simendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure).
Investigational

(S)-oxalosuccinic acid

Experimental

(Diaminomethyl-Methyl-Amino)-Acetic Acid

Experimental

1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea

Experimental

4-O-methyl-alpha-D-glucuronic acid

Experimental

1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA

Experimental

(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

Experimental

2-phenyl-1H-imidazole-4-carboxylic acid

Experimental

(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid

Experimental

2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE

Experimental

L-tartaric acid

Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes.Tartaric is an alpha-hydroxy-carboxylic acid, is diprotic and aldaric in acid characteristics, and is a dihydroxyl derivative of succinic acid.
Experimental

Orteronel

Orteronel has been investigated for the treatment of Prostate Cancer.
Investigational

Anecortave

Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).
Investigational

Glyceryl 1-oleate

Experimental

Aloxiprin

Experimental

Fimasartan

Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the...
Investigational

JE-2147

Experimental

Serine-3'-aminoadenosine

Experimental
Displaying drugs 7676 - 7700 of 9386 in total